BGI Genomic’s mission is simple: To provide researchers and healthcare professionals with quality genomic data and genetic testing solutions, at rapid turnaround times with industry leading pricing.
BGI Genomics is the world’s leading provider of genomic sequencing services and proteomic services, now serving customers in more than 100 countries. They provide academic institutions, pharmaceutical companies, health care providers and other organizations with integrated genomic sequencing and proteomic services and solutions across a broad range of applications spanning:
• Basic research covering human, plant, animal and microbial species
• Clinical research in human health
• Genetic testing and screening
• Drug discovery and development
• Agriculture and Biodiversity preservation and sustainability
With more than 20 years of genomics experience helping customers achieve their research goals by delivering rapid, high-quality results using a broad array of cost-effective, cutting-edge technologies, including their own innovative DNBseq™ sequencing technology, BGI is confident they can help meet your project needs.
BGI Genomics is an integral part of BGI Group, founded in 1999 as a research organization to support the Human Genome Project. Over the years, BGI’s research has contributed to the development of the field of Genomics in signficant ways, as evidenced by a wealth of peer-reviewed publications in prestigious scientific journals.
Today, BGI is actively participating in the fields of Cancer Research, Bio-sustainability and Personalized Medicine through a variety of subsidiaries and a global network of collaborators.
BGI Sequencing Technology
BGI provide sequencing services on cutting-edge next generation sequencing (NGS) platforms, including proprietary DNBSEQ™ technology platforms offering quality data at unrivalled pricing for a wide variety of sequencing services and clinical applications.
They offer one of the industry’s largest sequencing capacities and have a wide variety of other NGS platforms to meet all needs. Their technology, sequencing, capacity, and almost 20 years of genomics experience allows BGI to offer a trusted, cost efficient and expert service for all sequencing needs.
COVID and Respiratory Testing
BGI’s new CE certified 3-in-1 test For SARS-CoV-2, Influenza A and Influenza B provide clinicians and doctors with a reliable single-panel test to help quickly and accurately diagnose patients.
The NIFTY™ Test – The World’s Leading Non-Invasive Prenatal Test (NIPT). Over 6 MILLION Samples Processed To Date.
BGI Provides a Wide Range of Genomics Solutions for Reproductive Health, including carrier screening, PGS and chromosome sequencing.
Oncology & Precision Medicine
BGI provides a wide range of clinical and research solutions for oncology.